IL6 and endothelial dysfunction: Among circulating proinflammatory markers, C-reactive protein (CRP) and interleukin-6 (IL-6) have been extensively studied and are consistently associated with insulin resistance, endothelial dysfunction, and increased risk of cardiovascular events and mortality in T2D [8, 11, 12].